In the meanwhile, pancreas tissue sample was obtained, and a comprehensive genomic profiling was performed by high-throughput sequencing using a 520 cancer-related gene panel, which demonstrated RB1 p.Y454 and TP53 p.G266R variant (germline mutation). This evidence concerns the gene TP53 and cancer.